Maryam Shariati

1.8k total citations
6 papers, 486 citations indexed

About

Maryam Shariati is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Maryam Shariati has authored 6 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in Maryam Shariati's work include Advanced Breast Cancer Therapies (2 papers), Cancer-related molecular mechanisms research (1 paper) and Cancer-related Molecular Pathways (1 paper). Maryam Shariati is often cited by papers focused on Advanced Breast Cancer Therapies (2 papers), Cancer-related molecular mechanisms research (1 paper) and Cancer-related Molecular Pathways (1 paper). Maryam Shariati collaborates with scholars based in United States, Iran and Japan. Maryam Shariati's co-authors include Funda Meric‐Bernstam, Kurt W. Evans, Joseph H. Taube, Agata A. Tinnirello, Jeffrey M. Rosen, Sendurai A. Mani, Venkata Lokesh Battula, Steven J. Werden, Rudy Guerra and Nathalie Sphyris and has published in prestigious journals such as Blood, Cancer Research and Oncogene.

In The Last Decade

Maryam Shariati

6 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maryam Shariati United States	5	348	192	136	63	57	6	486
Anais Del Curatolo Malaysia	6	404 1.2×	155 0.8×	158 1.2×	83 1.3×	63 1.1×	7	546
Feng Xing China	12	492 1.4×	199 1.0×	124 0.9×	40 0.6×	83 1.5×	20	644
Siao Muk Cheng Taiwan	12	415 1.2×	136 0.7×	110 0.8×	59 0.9×	37 0.6×	26	598
Elisa Brighenti Italy	10	373 1.1×	250 1.3×	104 0.8×	57 0.9×	46 0.8×	15	567
Kristin M. Stadelman United States	9	465 1.3×	185 1.0×	158 1.2×	55 0.9×	55 1.0×	13	613
Ufuk Degirmenci Singapore	7	480 1.4×	128 0.7×	222 1.6×	57 0.9×	75 1.3×	7	653
Kibeom Jang United States	8	242 0.7×	202 1.1×	144 1.1×	43 0.7×	49 0.9×	10	438
Sumit Das India	5	283 0.8×	175 0.9×	123 0.9×	59 0.9×	28 0.5×	6	468
Nicolas Etique France	13	242 0.7×	148 0.8×	198 1.5×	46 0.7×	49 0.9×	20	511
Ursula Cesta Incani Italy	7	489 1.4×	187 1.0×	188 1.4×	106 1.7×	73 1.3×	9	703

Countries citing papers authored by Maryam Shariati

Since Specialization

Citations

This map shows the geographic impact of Maryam Shariati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maryam Shariati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maryam Shariati more than expected).

Fields of papers citing papers by Maryam Shariati

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maryam Shariati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maryam Shariati. The network helps show where Maryam Shariati may publish in the future.

Co-authorship network of co-authors of Maryam Shariati

This figure shows the co-authorship network connecting the top 25 collaborators of Maryam Shariati. A scholar is included among the top collaborators of Maryam Shariati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maryam Shariati. Maryam Shariati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Shariati, Maryam, Kurt W. Evans, Xiaofeng Zheng, et al.. (2021). Combined inhibition of DDR1 and CDK4/6 induces synergistic effects in ER-positive, HER2-negative breast cancer with PIK3CA/AKT1 mutations. Oncogene. 40(26). 4425–4439. 17 indexed citations

2.

Shariati, Maryam, et al.. (2019). Silymarin Restores Regulatory T Cells (Tregs) Function in Multiple Sclerosis (MS) Patients In Vitro. Inflammation. 42(4). 1203–1214. 12 indexed citations

3.

Shariati, Maryam & Funda Meric‐Bernstam. (2019). Targeting AKT for cancer therapy. Expert Opinion on Investigational Drugs. 28(11). 977–988. 224 indexed citations

4.

Matre, Polina, Maryam Shariati, Juliana Vélez, et al.. (2014). Efficacy of Novel Glutaminase Inhibitor CB-839 in Acute Myeloid Leukemia. Blood. 124(21). 3763–3763. 11 indexed citations

5.

Hollier, Brett G., Agata A. Tinnirello, Steven J. Werden, et al.. (2013). FOXC2 Expression Links Epithelial–Mesenchymal Transition and Stem Cell Properties in Breast Cancer. Cancer Research. 73(6). 1981–1992. 220 indexed citations

6.

Zoufan, Parzhak, et al.. (2010). PHYSIOLOGICAL AND MOLECULAR RESPONSES OF NRT2.4 TRANSPORTER UNDER N-STARVATION CONDITIONS IN ARABIDOPSIS THALIANA. 23(1). 94–107. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact